Crossref
E-labeling system in prescription medicines in Japan: measures and perspectives in pharmaceutical industry
Translational and Regulatory Sciences · 2022 · 4 (1) · 12-19
DOI: 10.33611/trs.2022-001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational and Regulatory Sciences, 2022. Verfasst von Makoto NAGAOKA und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
NAGAOKA, M., & TAKAMINE, T. (2022). E-labeling system in prescription medicines in Japan: measures and perspectives in pharmaceutical industry. Translational and Regulatory Sciences, 4(1), 12-19. https://doi.org/10.33611/trs.2022-001
Vancouver
NAGAOKA M, TAKAMINE T. E-labeling system in prescription medicines in Japan: measures and perspectives in pharmaceutical industry. Translational and Regulatory Sciences. 2022;4(1):12-19. doi:10.33611/trs.2022-001
BibTeX
@article{NAGAOKA2022,
author = {NAGAOKA, Makoto and TAKAMINE, Tamaki},
title = {E-labeling system in prescription medicines in Japan: measures and perspectives in pharmaceutical industry},
journal = {Translational and Regulatory Sciences},
year = {2022},
volume = {4},
number = {1},
pages = {12--19},
doi = {10.33611/trs.2022-001}
}
EUVIMED